These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7583243)

  • 1. Modulation by inositol of cholinergic- and serotonergic-induced seizures in lithium-treated rats.
    Williams MB; Jope RS
    Brain Res; 1995 Jul; 685(1-2):169-78. PubMed ID: 7583243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of brain myo-inositol levels in rats increases latency to lithium-pilocarpine seizures.
    Kofman O; Sherman WR; Katz V; Belmaker RH
    Psychopharmacology (Berl); 1993; 110(1-2):229-34. PubMed ID: 7870890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium potentiates phosphoinositide-linked 5-HT receptor stimulation in vivo.
    Williams MB; Jope RS
    Neuroreport; 1994 May; 5(9):1118-20. PubMed ID: 8080969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive rat brain immediate early gene responses to seizures induced by lithium plus pilocarpine.
    Williams MB; Jope RS
    Brain Res Mol Brain Res; 1994 Aug; 25(1-2):80-9. PubMed ID: 7984056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inositol trisphosphate, cyclic AMP, and cyclic GMP in rat brain regions after lithium and seizures.
    Jope RS; Song L; Kolasa K
    Biol Psychiatry; 1992 Mar; 31(5):505-14. PubMed ID: 1316177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that phosphoinositide metabolism in rat cerebral cortex stimulated by pilocarpine, physostigmine, and pargyline in vivo is not changed by chronic lithium treatment.
    Honchar MP; Vogler GP; Gish BG; Sherman WR
    J Neurochem; 1990 Nov; 55(5):1521-5. PubMed ID: 2170579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of peripheral inositol injection on rat motor activity models of depression.
    Kofman O; Bersudsky Y; Vinnitsky I; Alpert C; Belmaker RH
    Isr J Med Sci; 1993 Sep; 29(9):580-6. PubMed ID: 8225947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myo-inositol attenuates two specific behavioral effects of acute lithium in rats.
    Kofman O; Belmaker RH; Grisaru N; Alpert C; Fuchs I; Katz V; Rigler O
    Psychopharmacol Bull; 1991; 27(3):185-90. PubMed ID: 1775587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose peripheral inositol raises brain inositol levels and reverses behavioral effects of inositol depletion by lithium.
    Agam G; Shapiro Y; Bersudsky Y; Kofman O; Belmaker RH
    Pharmacol Biochem Behav; 1994 Oct; 49(2):341-3. PubMed ID: 7824547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the ability of myo-inositol and epi-inositol to attenuate lithium-pilocarpine seizures in rats.
    Patishi Y; Belmaker RH; Bersudsky Y; Kofman O
    Biol Psychiatry; 1996 May; 39(9):829-32. PubMed ID: 8731528
    [No Abstract]   [Full Text] [Related]  

  • 11. Epi-inositol and inositol depletion: two new treatment approaches in affective disorder.
    Bersudsky Y; Einat H; Stahl Z; Belmaker RH
    Curr Psychiatry Rep; 1999 Dec; 1(2):141-7. PubMed ID: 11122916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lithium on phosphoinositide metabolism in vivo.
    Sherman WR; Gish BG; Honchar MP; Munsell LY
    Fed Proc; 1986 Oct; 45(11):2639-46. PubMed ID: 3019784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium-pilocarpine seizures as a model for lithium action in mania.
    Belmaker RH; Bersudsky Y
    Neurosci Biobehav Rev; 2007; 31(6):843-9. PubMed ID: 17602744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status epilepticus is produced by administration of cholinergic agonists to lithium-treated rats: comparison with kainic acid.
    Morrisett RA; Jope RS; Snead OC
    Exp Neurol; 1987 Dec; 98(3):594-605. PubMed ID: 2824229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of acute and chronic lithium treatment on pilocarpine-stimulated phosphoinositide hydrolysis in mouse brain in vivo.
    Whitworth P; Heal DJ; Kendall DA
    Br J Pharmacol; 1990 Sep; 101(1):39-44. PubMed ID: 2178020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilocarpine toxicity in retinal ganglion cells.
    Vorwerk CK; Simon P; Gorla M; Katowitz W; Zurakowski D; Levin LA; Dreyer EB
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):813-6. PubMed ID: 10067991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the putative lithium mimetic ebselen on pilocarpine-induced neural activity.
    Singh N; Serres F; Toker L; Sade Y; Blackburn V; Batra AS; Saiardi A; Agam G; Belmaker RH; Sharp T; Vasudevan SR; Churchill GC
    Eur J Pharmacol; 2020 Sep; 883():173377. PubMed ID: 32687920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium.
    Williams MB; Jope RS
    Psychopharmacology (Berl); 1995 Dec; 122(4):363-8. PubMed ID: 8657834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats.
    Honchar MP; Olney JW; Sherman WR
    Science; 1983 Apr; 220(4594):323-5. PubMed ID: 6301005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nifedipine on lithium-pilocarpine-induced seizures in the rats.
    Wielosz M; Młynarczyk M; Kleinrok Z
    Pol J Pharmacol; 1995; 47(4):279-84. PubMed ID: 8616505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.